Tirzepatide — molecular reference
Tirzepatide is a synthetic 39-amino-acid dual agonist of the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. Researchers use it in receptor binding, cAMP accumulation, and β-arrestin recruitment assays to compare dual-incretin pharmacology against selective GLP-1R or GIP-R agonists. Its C20 fatty-diacid acylation supports extended in-vitro stability in cultured adipocyte, hepatocyte, and β-cell models. Supplied as a sterile lyophilized powder for reconstitution in bacteriostatic water. For laboratory research use only — not for human or veterinary use.
Molecular data
- Compound name
- Tirzepatide (GLP-1 / GIP Dual Agonist)
- Also referenced as
- GLP-2
- Research classification
- Peptide Hormone & Analog
- Molecular formula
- C225H348N48O68
- Average molecular mass
- ≈ 4810 Da(published value)
- Research pathway
- Metabolic Pathway
- Physical form
- Lyophilized powder
- Storage & handling
- Store lyophilized at -20°C. Protect from light.
- Available presentations
- 10mg · 20mg · 30mg · 50mg
- Current status
- In Stock
Fields with no verifiable source are omitted rather than estimated. Where an average mass is marked as calculated, it is derived arithmetically from the molecular formula using IUPAC standard atomic weights, not measured.
Documented assay contexts
Contexts in which this compound is used as a reference material in published in-vitro work. These describe laboratory usage, not effects in any organism.
- GLP-1R / GIP-R co-activation assays
- cAMP / β-arrestin recruitment studies
- Metabolic pathway comparison models
Lot documentation
| Lot | Presentation | Purity | Certificate |
|---|---|---|---|
| PH260802 | 10mg | 99.74% | View certificate |
| PH260810 | 50mg | — | Testing in progress |
| PH260818 | 20mg | — | Testing in progress |
| PH260820 | 30mg | — | Testing in progress |